Bayer Sevabertinib gets USFDA Priority Review status for HER2-mutant non-small cell lung cancer Written By Ruchika Sharma29 May 2025 11:15 AM ISTBerlin: Bayer has received Priority Review status from the US Food and Drug Administration (FDA) for the investigational compound sevabertinib...
Bayer begins Phase I study with GIRK4 inhibitor for atrial fibrillation Written By Ruchika Sharma25 May 2025 11:00 AM ISTBerlin: Bayer has announced initiation of a Phase I clinical trial with BAY 3670549, an investigational highly selective G-protein-coupled...
Bayer-Regeneron Eylea 8 mg approved in China for wet age-related macular degeneration Written By Ruchika Sharma22 May 2025 3:30 PM ISTBerlin: Bayer has received approval from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) for Eylea 8...
Bayer Jivi gets USFDA approval for pediatric patients 7 years of age and older with hemophilia A Written By Ruchika Sharma21 May 2025 2:50 PM ISTThe approval is based on data from the Alfa-PROTECT and PROTECT Kids studies.
Bayer seeks Japenese nod for Aflibercept to treat macular edema following retinal vein occlusion Written By Ruchika Sharma11 May 2025 1:45 PM ISTBerlin: Bayer has submitted an application to the Japanese Ministry of Health, Labour and Welfare (MHLW) seeking approval of aflibercept 8 mg...
Bayer begins Phase I study targeting GPC3 with alpha radiopharmaceutical in advanced hepatocellular carcinoma patients Written By Ruchika Sharma4 May 2025 12:30 PM ISTBerlin: Bayer has announced the initiation of a Phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational targeted alpha...
Bayer appoints Guru Ramamurthy as new CFO for Crop Science division Ruchika Sharma29 April 2025 12:25 PM ISTMonheim: Bayer has announced that Guru Ramamurthy will become the new Chief Financial Officer (CFO) for Bayer's Crop Science division. He will...
Bayer seeks EMA approval for Aflibercept for retinal vein occlusion treatment Written By Ruchika Sharma9 April 2025 1:41 PM ISTBerlin: Bayer has submitted an application to the European Medicines Agency (EMA) seeking approval of aflibercept 8 mg (114.3 mg/ml solution...
Bayer arm AskBio elects Independent Director Dr Laura Sepp Lorenzino to Board Ruchika Sharma9 April 2025 11:30 AM ISTResearch Triangle Park: AskBio Inc., a gene therapy company wholly owned and independently operated subsidiary of Bayer AG, has announced...
Bayer eyes launch of heart, menopause relief drugs in 2025 Written By Ruchika Sharma8 April 2025 12:30 PM ISTLondon: Bayer said it is gearing up to launch two new pharmaceutical products this year, each with the potential to generate more than $1 billion in...
Bayer Takes Roundup Cancer Case Back to Supreme Court Written By Farhat Nasim5 April 2025 10:45 AM ISTBayer has warned U.S. lawmakers it might halt Roundup sales to farmers, unless they can strengthen legal protection against the litigation.
Bayer AG arm Vividion Therapeutics doses first patient in Phase I study of Inhibitor for advanced solid tumors treatment Written By Ruchika Sharma4 April 2025 10:30 AM ISTSan Diego: Vividion Therapeutics, Inc. has announced that the first patient has been dosed in a Phase I clinical trial evaluating VVD-159642, an...
